Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.

@article{Adunsky2004PlasmaLL,
  title={Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.},
  author={Abraham Adunsky and Vladimir Chesnin and Ramit Ravona and Dror Harats and Michael Davidson},
  journal={Archives of gerontology and geriatrics},
  year={2004},
  volume={38 1},
  pages={61-8}
}
Donepezil hydrochloride is a central acetylcholine esterase inhibitor that is widely used in Alzheimer disease (AD). We have recently observed some differences in lipid profile between occasional cases of Donepezil hydrochloride users (DU) and non-users (DNU). This prompted us to study the levels of plasma lipids in these two groups, cross-sectionally. The medical charts of patients with probable AD were screened for current use of Donepezil hydrochloride and lipids profile, along with other… CONTINUE READING

From This Paper

Topics from this paper.
3 Citations
0 References
Similar Papers

Similar Papers

Loading similar papers…